Clinical trials - Press Releases

Date	Title	Company
06-Feb-2023	RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies	CluePoints
03-Feb-2023	Asia Pacific Cell & Gene Research Growing 50% Faster than ROW	Novotech, Asia Pacific CRO
03-Feb-2023	New Phesi analysis reveals almost a fifth of investigator sites in cancer trials have recruited only one patient	Phesi Inc
03-Feb-2023	Anaveon doses first patient in a Phase I/II Study of ANV419 as monotherapy or in combination with check point inhibitors in patients with advanced melanoma	Anaveon
02-Feb-2023	AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials	AARDEX Group
01-Feb-2023	MURAL HEALTH AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS	Mural Health
26-Jan-2023	AC Immune’s ACI-24.060 Anti-Amyloid Beta Vaccine for Alzheimer’s Shows Positive Initial Interim Safety and Immunogenicity in Phase 1b/2 ABATE Trial	AC Immune SA
26-Jan-2023	Cherwell publishes new guide to EM best practice in compliance with revised Annex 1	Cherwell Laboratories
26-Jan-2023	Future of clinical research in the NHS in jeopardy without urgent action, warns Lords Committee	House of Lords
26-Jan-2023	Almac Group Opens Registration for Internationally Recognised Process Chemistry Forum in Belfast	Almac Group
26-Jan-2023	New spray fights infections and antibiotic resistance	The World Health Organization
26-Jan-2023	Douglas Pharmaceuticals Announces Formation of Clinical Advisory Board for Lead Program R-107	Douglas Pharmaceuticals
26-Jan-2023	ONXEO provides update on the Development Program for its first-in-class drug candidate AsiDNATM	Onxeo
26-Jan-2023	Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease	Orbsen Therapeutics Limited
26-Jan-2023	Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III	Novartis
26-Jan-2023	First CAR T-cell therapy recommended for routine use on the NHS in England	Gilead Sciences Ltd
26-Jan-2023	Blackford and Brainomix Announce AI Partnership for Stroke Care	Blackford
26-Jan-2023	Bloomsbury Genetic Therapies Announces Orphan Drug Designations of BGT-DTDS for the Treatment of Dopamine Transporter Deficiency Syndrome	Bloomsbury Genetic Therapies Limited
26-Jan-2023	Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize	University of Calgary
26-Jan-2023	Nutricia pioneers its first plant-based medical nutrition drink	Nutricia